A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

NCT07101679 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: LICSBR

Sponsor

West China Hospital